Skip to Content Facebook Feature Image

CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP

News

CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP
News

News

CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP

2026-03-25 20:52 Last Updated At:21:01

CAROLINA, Puerto Rico & BOSTON--(BUSINESS WIRE)--Mar 25, 2026--

CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, today announced the first clinical deployment of Ibex Prostate for Transurethral Resection of the Prostate (TURP), an AI solution for rapid, high-volume diagnostic support.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260325775149/en/

CorePlus and Ibex have deployed Ibex Prostate for TURP within a Lab Developed Test (LDT) workflow for enhanced diagnostic support. This initiative expands the organizations’ longstanding collaboration and marks a new chapter in the real-world integration of artificial intelligence into routine clinical pathology.

CorePlus has achieved a significant clinical milestone, having surpassed 250,000 AI-based diagnostic analyses in routine practice using the Ibex platform. This extensive real-world deployment—one of the largest of its kind—underscores the company’s clinical credibility and reinforces its position as a pioneer in integrating AI into routine digital pathology.

Reviewing large volumes of tissue and identifying small malignant foci in TURPs cases can be labor-intensive for pathologists. Ibex Prostate provides pathologists with case-level AI findings for triaging, flags high-priority slides and highlights critical regions of interest for pathologists' review.

“TURP specimens represent one of the most challenging diagnostic scenarios in pathology, where high volume and low cancer prevalence demand both efficiency and precision,” said Mariano de Socarraz, CEO of CorePlus. “Our commitment at CorePlus is to lead the transformation toward precision pathology, where advanced technologies enable more accurate, consistent, and clinically actionable diagnoses. By integrating Ibex Prostate for TURP into our workflow, we are strengthening our ability to deliver the highest standard of care for patients undergoing prostate cancer evaluation.”

This deployment follows CorePlus’s history of innovation, including being the first laboratory in the Americas to deploy AI for prostate and breast biopsies, and publishing groundbreaking peer-reviewed research on AI-driven diagnostic accuracy. By integrating Ibex Prostate for TURP into their primary diagnostic workflow, CorePlus continues to address the global demand for efficient, high-accuracy cancer diagnostics.

"Our collaboration with CorePlus demonstrates how AI can be successfully integrated into routine clinical practice at scale," said Yair Heller, CEO of Ibex Medical Analytics. "CorePlus’s extensive experience makes them an ideal partner for the deployment of Ibex Prostate for TURP, bringing advanced diagnostic tools to patients undergoing these critical procedures."

The announcement coincides with the USCAP 2026 Annual Meeting, where CorePlus is being recognized for its contributions to the field and its commitment to digital transformation.

About CorePlus

CorePlus is a pioneering healthcare technology company dedicated to revolutionizing patient care through innovative diagnostic solutions. By integrating advanced artificial intelligence with state-of-the-art medical technologies, CorePlus delivers tools that empower clinicians to achieve greater accuracy, efficiency, and confidence in their diagnoses. With a focus on transforming complex laboratory workflows, CorePlus ensures seamless interoperability through its adaptable platforms, providing tailored solutions that address the evolving needs of modern healthcare. Driven by a commitment to improving patient outcomes, CorePlus continues to set new benchmarks in precision diagnostics and personalized medicine. For more information, visit www.corepluspr.com.

About Ibex Medical Analytics

Ibex Medical Analytics is transforming cancer diagnostics with clinical grade AI-powered solutions for pathology. Empowering clinicians and supporting pathologists, Ibex is on a mission to provide accurate, timely and personalized cancer diagnosis for every patient. Ibex is the first and most widely deployed AI-powered platform in pathology. Pathologists worldwide use Ibex as part of their everyday routine to improve the accuracy of cancer diagnosis, implement comprehensive quality control measures, reduce turnaround times and boost productivity with more efficient workflows. For additional company information, please visit https://ibex-ai.com/ and follow us on LinkedIn and X.

The Ibex platform includes solutions that are CE-IVD certified and registered with MHRA, TGA, ANVISA, AMAR, and Swissmedic. It includes an FDA-cleared solution and others that are Research Use Only (RUO) in the U.S. The Ibex suite includes solutions utilized by CorePlus as part of a Laboratory Developed Test (LDT), which has not been cleared or approved by the FDA.

Dr. Mariano de Socarraz and Dr. Juan Santa from CorePlus receiving the Ibex Trailblazer Achievement Award for surpassing 250,000 AI-based diagnostic analyses in routine practice.

Dr. Mariano de Socarraz and Dr. Juan Santa from CorePlus receiving the Ibex Trailblazer Achievement Award for surpassing 250,000 AI-based diagnostic analyses in routine practice.

GRAPEVINE, Texas (AP) — Conservatives are holding one of their largest annual gatherings at a perilous political moment for President Donald Trump and with open division on the right over the war he launched in Iran.

While Trump maintains broad support among conservatives, the war in Iran is more than a wrinkle for activists drawn to his “America First” campaign pledge against getting involved in foreign conflicts. A new AP-NORC poll shows about 59% of Americans think the military action in Iran is excessive. The debate will be a subtext — and likely flare publicly — as thousands of activists, influencers and Republican lawmakers gather at the Conservative Political Action Conference that begins Wednesday outside Dallas.

The event also comes a day after a Democrat flipped the Florida state legislative seat that's home to Trump's Mar-a-Lago estate.

The gathering will be a contrast to the celebratory meeting one year ago when Trump, newly returned to office, vowed to “forge a new and lasting political majority” and Elon Musk wielded a chain saw to symbolize how the Republican administration was slashing the government workforce and red tape.

This year, neither Trump nor Vice President JD Vance has been publicly announced as speaking to the gathering. But among those who are slated to speak are big names in the MAGA movement who have voiced conflicting views on the Iran war.

"This is obviously going to be a hot topic,” said John Gizzi, a CPAC veteran and columnist for the conservative media outlet Newsmax, who noted the possibility of greater U.S. involvement over an uncertain length of time.

Among the featured speakers scheduled at the four-day event is longtime Trump ally Steve Bannon. Bannon said during his “War Room” podcast this month that should the war become “a hard slog," it could cost the GOP conservative voters ahead of the midterms.

“We are going to bleed support,” Bannon said.

Texas Sen. Ted Cruz, who supports the war, also is on the agenda at the Gaylord Texan Resort and Convention Center.

“I think President Trump was exactly right to act to protect Americans,” Cruz said last week in a CBS News interview.

Former Florida Rep. Matt Gaetz’s scheduled speaking slot is a reminder of the disagreement among some conservatives about the U.S. military alliance with Israel against Iran.

Gaetz, host of a show on the conservative One America News Network, has said the U.S. has been too cozy with Israel as popular conservative personalities such as Tucker Carlson have challenged conservatives’ longtime bond with the country, prompting criticism from GOP groups, including pro-Israel Republicans, of antisemitism.

Others scheduled to speak include Trump border czar Tom Homan and former Republican National Committee Chairman Michael Whatley, who is running for the U.S. Senate in North Carolina.

A year after Trump presided over the group's jubilant conference upon his return to office, he is in a much different place.

At war while worries about jobs and household costs linger, his approval is down. His signature domestic policy, aimed at tightening voting rules ahead of November's midterm elections, has stalled in a Congress his party controls, while the House Republican majority is in jeopardy and the party's hold on the Senate is less certain than a year ago.

Despite the dividing lines, Trump enjoys enduring approval from his party’s right flank. Eighty-six percent of conservatives said they approved of the president’s job performance in a February AP-NORC poll.

And while Trump's supporters remain devoted, some within the most conservative circles say division over Iran could signal trouble for Republicans in November.

Texas Rep. Steve Toth, who plans to attend CPAC, suggested that Trump’s support remains robust among conservatives but that Republican messaging on the war could be stronger.

“From MAGA people, for the most part, I don’t hear frustration with the president,” said Toth, who beat incumbent Republican Rep. Dan Crenshaw in Texas’ March 3 primary. “I don’t know that we’re doing a great job at communicating the full ramifications.”

Another stark reminder of the contrast with last year is Texas' unresolved Senate primary, a particular political headache for Trump.

Texas Attorney Gen. Ken Paxton, who is challenging four-term GOP Sen. John Cornyn, not only is attending the event but also has one of the event's premier speaking roles, the Ronald Reagan Dinner on Friday evening. Cornyn is not attending the Texas conference.

Trump said three weeks ago he would soon endorse one of them after Paxton finished narrowly behind Cornyn in the March 3 primary, though neither received a majority to avoid a May 26 runoff.

Trump implored whoever didn't get the endorsement to drop out, writing in a social media post that the bitter contest “cannot, for the good of the Party, and our Country, itself, be allowed to go on any longer.”

The deadline for candidates to remove their names from the May 26 runoff ballot passed last week, as Paxton and Cornyn were launching stepped-up attack ads targeting one another.

Catalini reported from Morrisville, Pa. Associated Press writer Amelia Thomson DeVeaux in Washington contributed to this report.

President Donald Trump arrives on Air Force One, Wednesday, March 18, 2026, at Joint Base Andrews, Md., after attending the casualty return at Dover Air Force Base, Del., for the six crew members of an Air Force refueling aircraft who died when their plane crashed in western Iraq while supporting operations against Iran. (AP Photo/Julia Demaree Nikhinson)

President Donald Trump arrives on Air Force One, Wednesday, March 18, 2026, at Joint Base Andrews, Md., after attending the casualty return at Dover Air Force Base, Del., for the six crew members of an Air Force refueling aircraft who died when their plane crashed in western Iraq while supporting operations against Iran. (AP Photo/Julia Demaree Nikhinson)

Recommended Articles